Innovations In Medicine
Stay current with the science shaping the future of healthcare with Innovations in Medicine. Here, leading clinicians, researchers, and scientific experts come together to examine emerging evidence and to share their expert perspectives across therapeutic areas so that you can gain a deeper understanding of today's clinical landscape and tomorrow's standards of care.
1-15 of 17
Earlier ESR1m Detection May Delay Endocrine Resistance in HR+/HER2- Advanced Breast Cancer
Innovations In MedicineEarlier ESR1m Detection May Delay Endocrine Resistance in HR+/HER2- Advanced Breast Cancer
Putting Into Practice: ctDNA Monitoring of ESR1 Mutations During 1L HR+/HER2− Advanced Breast Cancer
Innovations In MedicinePutting Into Practice: ctDNA Monitoring of ESR1 Mutations During 1L HR+/HER2− Advanced Breast Cancer
Centanafadine for Management of Executive Dysfunction and Emotional Dysregulation in Children and Adolescents with ADHD
Innovations In MedicineCentanafadine for Management of Executive Dysfunction and Emotional Dysregulation in Children and Adolescents with ADHD
Jennifer Caudle, DO, FACOFP
Greg Mattingly, MD
Navigating ASCVD and Pancreatitis Risk in Severe Hypertriglyceridemia
Innovations In MedicineNavigating ASCVD and Pancreatitis Risk in Severe Hypertriglyceridemia
Charles Turck, PharmD, BCPS, BCCCP
Andrew Freeman, MD, FACC, FACP
Evaluating a HIF-PHI for Anemia in In-Center Hemodialysis
Innovations In MedicineEvaluating a HIF-PHI for Anemia in In-Center Hemodialysis
Matt Birnholz, MD
Gates B. Colbert, MD
Varshi Broumand, MD, FASN
The First Approved All-Oral, Fixed Duration Treatment for CLL: Insights from the AMPLIFY Trial
Project Oncology®The First Approved All-Oral, Fixed Duration Treatment for CLL: Insights from the AMPLIFY Trial
Jennifer Caudle, DO, FACOFP
Nicole Lamanna, MD
- advertisement
Seeing the Full Picture of ADHD: Beyond Core Symptoms
Innovations In MedicineSeeing the Full Picture of ADHD: Beyond Core Symptoms
Andrew J. Cutler, MD
Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC
Understanding Sedation and Somnolence with Brexpiprazole in Agitation: What the Data Show
Innovations In MedicineUnderstanding Sedation and Somnolence with Brexpiprazole in Agitation: What the Data Show
George Grossberg, MD
Marc E. Agronin, MD
Two Lenses on Migraine: Managing Incomplete Acute Treatment Response
Innovations In MedicineTwo Lenses on Migraine: Managing Incomplete Acute Treatment Response
Fallon Schloemer, DO
Susan Hutchinson, MD
Ocular Management in PROC: Insights on Collaborative Care Across Practice Settings
Project Oncology®Ocular Management in PROC: Insights on Collaborative Care Across Practice Settings
Jennifer Caudle, DO, FACOFP
Ida Micaily, MD
Jeffrey Varanelli, OD
Integrating Patient Perspectives in Dermatologic Care
DermConsultIntegrating Patient Perspectives in Dermatologic Care
Mona Shahriari MD, FAAD
Linda Stein Gold, MD
Jennifer Soung, MD
On the Frontline: Empowering IO Therapies for Patients with HER2-Negative G/GEJC
Project Oncology®On the Frontline: Empowering IO Therapies for Patients with HER2-Negative G/GEJC
Charles Turck, PharmD, BCPS, BCCCP
Jun Gong, MD
- advertisement
Challenging Cases in IgA Nephropathy and Identifying Patients for Specialized Care
Medical Industry FeatureChallenging Cases in IgA Nephropathy and Identifying Patients for Specialized Care
Jaimini Patel, PharmD, BCCCP
Sayna Norouzi, MD
Immunotherapy Advances in Early-Stage Upper GI Cancers: Key Trial Insights
Project Oncology®Immunotherapy Advances in Early-Stage Upper GI Cancers: Key Trial Insights
Jennifer Caudle, DO, FACOFP
Ronan J. Kelly MD, MBA, FASCO
Selecting First-Line Therapy in Gastric Cancers: A Biomarker-Driven Approach
Project Oncology®Selecting First-Line Therapy in Gastric Cancers: A Biomarker-Driven Approach
Jennifer Caudle, DO, FACOFP
Samuel Klempner, MD
Nataliya Uboha, MD, PhD
